Search

everythinglearnresearchcommunity

for

Search:↓

The P133R mutation in AKR1D1 enzyme causes harmful bile acid buildup, explaining related health issues.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

Upadacitinib improved multiple immune-related conditions in one patient.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Adding a second method to PROTACs could improve cancer treatment.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

Potassium channel modulators mostly increase the activity of rat whisker mechanoreceptors.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Inward rectifier potassium channels are important in many body functions and diseases, and could be potential drug targets.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

The document's conclusion cannot be provided because the document is not available or cannot be read.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

The compound 4c showed strong potential as an anticancer agent.

CTP-543 is generally safe for treating alopecia areata.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.